Water

Water

SCHEMBL7526796

Nc1cc(Cl)c(NC(=O)CN2CCN(CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(Cl)c1.Nc1cc(Cl)c(NC(=O)CN2CCN(CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(Cl)c1.O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 6/20 0.62
DRD3 known ✓ P35462 6/20 0.62
OPRK1 known ✓ P41145 6/20 0.62
SLC6A3 known ✓ Q01959 6/20 0.62
OPRD1 known ✓ P41143 5/20 0.62
HRH1 known ✓ P35367 5/20 0.62
ADRA1A known ✓ P35348 4/20 0.62
DRD2 known ✓ P14416 4/20 0.62
ADORA3 known ✓ P0DMS8 3/20 0.62
SLC6A2 known ✓ P23975 3/20 0.62
SLC6A4 known ✓ P31645 3/20 0.62
HTR2B known ✓ P41595 3/20 0.62
MEN1 known ✓ O00255 2/20 0.62
ADRA2B known ✓ P18089 2/20 0.62
ADRA2C known ✓ P18825 2/20 0.62
ADRB1 known ✓ P08588 1/20 0.62
ADRA2A known ✓ P08913 1/20 0.62
CHRM3 known ✓ P20309 1/20 0.62
AGTR1 known ✓ P30556 1/20 0.62
GHSR known ✓ Q92847 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL9362242 1.00 SLC29A1 (0.75) SLC29A1KCNH2HTR2ADRD3OPRK1
SCHEMBL7517455 0.99 SLC29A1 (0.76) SLC29A1KCNH2HTR2ADRD3OPRK1
Hydrochloric Acid SCHEMBL7810744 0.98 SLC29A1 (0.75) SLC29A1KCNH2HTR2ADRD3OPRK1
SCHEMBL9030901 0.90 SLC29A1 (0.64) SLC29A1KCNH2HTR2ADRD3OPRK1
Draflazine SCHEMBL9410932 0.87 SLC29A1 (0.98) SLC29A1KCNH2HTR2ADRD3OPRK1
Draflazine SCHEMBL9362256 0.87 SLC29A1 (0.98) SLC29A1KCNH2HTR2ADRD3OPRK1
SCHEMBL7808271 0.87 SLC29A1 (0.80) SLC29A1KCNH2HTR2ADRD3OPRK1
Draflazine SCHEMBL7705425 0.86 SLC29A1 (1.00) SLC29A1KCNH2HTR2ADRD3OPRK1
Draflazine SCHEMBL215826 0.86 SLC29A1 (1.00) SLC29A1KCNH2HTR2ADRD3OPRK1
Hydrochloric Acid SCHEMBL9808242 0.85 SLC29A1 (0.86) SLC29A1KCNH2HTR2ADRD3OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0577171-B1 Use of piperazine acetamide derivatives against reperfusion damage JANSSEN PHARMACEUTICA NV (BE) 2002-03-06 EP disclosed